Ann: Incannex Launches Psychedelic Clinics Business, page-115

First 115 Last

Share
Profile

Follow
UncleJay

148 Posts.

35

18/03/23

07:53

Post #: 66835355
Share

Originally posted by sylau90: ↑

I really appreciate the time you put into writing all this. Again you have gone a long way or answering a simple question, it may seem wise, but is it??? I am not sure.

If BP wanted to takeover, why would they give the BOD an offer? They can simply buy on market at it's current price. Then slowly increase the stake to gain central management. Even better, when they make themselves eligible to participate in the next potential cap raise. Who in the right would go and give a beaten up speccies an offer now?

Even on market buying wouldn't push up the price by too much IMO, insert the reasons you listed why they should wait here.

I think you have answered your own questions here, APIRx is worth the investment. So I would say that IHL would be worth for BP

Now the real reason why BP hasn't Action yet? You maybe somewhat right with your long winded post, they are waiting for some asset to come to fruition. However, I am more leaning towards the followings:

1) they have better products up their sleeves
2) they are waiting for IHL to get more bargain
3) they don't think the drugs IHL have is up to standard as they have to resources to simulate and test the potential result.

Expand

It seems you’ve already made your mind up. Just don’t buy the stock? Simple.

IHL Price at posting: 11.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

I88

Soil sampling extends Portland Creek uranium target by 340% for Infini

QGL

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

JBY

James Bay latest lithium player to pivot to other metals amidst slump

WML

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint